Wyślij emailem: CAUSMIC (First US Randomized Controlled Trial Utilizing 3‐dimensional Guided, Catheter‐based Delivery of Autologous Skeletal Myoblasts for Ischemic Cardiomyopathy: Feasibility, Safety and Improvement in Cardiac Performance)